110 research outputs found
A benign juvenile environment reduces the strength of antagonistic pleiotropy and genetic variation in the rate of senescence
The environment can play an important role in the evolution of senescence because the optimal allocation between somatic maintenance and reproduction depends on external factors influencing life expectancy.
The aims of this study were to experimentally test whether environmental conditions during early life can shape senescence schedules, and if so, to examine whether variation among individuals or genotypes with respect to the degree of ageing differs across environments.
We tested life-history plasticity and quantified genetic effects on the pattern of senescence across different environments within a reaction norm framework by using an experiment on the three-spined stickleback (Gasterosteus aculeatus, Linnaeus) in which F1 families originating from a wild annual population experienced different temperature regimes.
Male sticklebacks that had experienced a more benign environment earlier in life subsequently reduced their investment in carotenoid-based sexual signals early in the breeding season, and consequently senesced at a slower rate later in the season, compared to those that had developed under harsher conditions. This plasticity of ageing was genetically determined. Both antagonistic pleiotropy and genetic variation in the rate of senescence were evident only in the individuals raised in the harsher environment.
The experimental demonstration of genotype-by-environment interactions influencing the rate of reproductive senescence provides interesting insights into the role of the environment in the evolution of life histories. The results suggest that benign conditions weaken the scope for senescence to evolve and that the dependence on the environment may maintain genetic variation under selection
Analytical solution of a generalized Penna model
In 1995 T.J.Penna introduced a simple model of biological aging. A modified
Penna model has been demonstrated to exhibit behaviour of real-life systems
including catastrophic senescence in salmon and a mortality plateau at advanced
ages. We present a general steady-state, analytic solution to the Penna model,
able to deal with arbitrary birth and survivability functions. This solution is
employed to solve standard variant Penna models studied by simulation.
Different Verhulst factors regulating both the birth rate and external death
rate are considered.Comment: 6 figure
The Heumann-Hotzel model for aging revisited
Since its proposition in 1995, the Heumann-Hotzel model has remained as an
obscure model of biological aging. The main arguments used against it were its
apparent inability to describe populations with many age intervals and its
failure to prevent a population extinction when only deleterious mutations are
present. We find that with a simple and minor change in the model these
difficulties can be surmounted. Our numerical simulations show a plethora of
interesting features: the catastrophic senescence, the Gompertz law and that
postponing the reproduction increases the survival probability, as has already
been experimentally confirmed for the Drosophila fly.Comment: 11 pages, 5 figures, to be published in Phys. Rev.
Why Y chromosome is shorter and women live longer?
We have used the Penna ageing model to analyze how the differences in
evolution of sex chromosomes depend on the strategy of reproduction. In
panmictic populations, when females (XX) can freely choose the male partner
(XY) for reproduction from the whole population, the Y chromosome accumulates
defects and eventually the only information it brings is a male sex
determination. As a result of shrinking Y chromosome the males become
hemizygous in respect to the X chromosome content and are characterized by
higher mortality, observed also in the human populations. If it is assumed in
the model that the presence of the male is indispensable at least during the
pregnancy of his female partner and he cannot be seduced by another female at
least during the one reproduction cycle - the Y chromosome preserves its
content, does not shrink and the lifespan of females and males is the same.
Thus, Y chromosome shrinks not because of existing in one copy, without the
possibility of recombination, but because it stays under weaker selection
pressure; in panmictic populations without the necessity of being faithful, a
considerable fraction of males is dispensable and they can be eliminated from
the population without reducing its reproduction potential.Comment: 8 pages, 5 figure
Immunosenescence in wild animals:Meta-analysis and outlook
Immunosenescence, the decline in immune defense with age, is an important mortality source in elderly humans but little is known of immunosenescence in wild animals. We systematically reviewed and meta-analysed evidence for age-related changes in immunity in captive and free-living populations of wild species (321 effect sizes in 62 studies across 44 species of mammals, birds and reptiles). As in humans, senescence was more evident in adaptive (acquired) than innate immune functions. Declines were evident for cell function (antibody response), the relative abundance of naive immune cells and an in vivo measure of overall immune responsiveness (local response to phytohaemagglutinin injection). Inflammatory markers increased with age, similar to chronic inflammation associated with human immunosenescence. Comparisons across taxa and captive vs free-living animals were difficult due to lack of overlap in parameters and species measured. Most studies are cross-sectional, which yields biased estimates of age-effects when immune function co-varies with survival. We therefore suggest longitudinal sampling approaches, and highlight techniques from human cohort studies that can be incorporated into ecological research. We also identify avenues to address predictions from evolutionary theory and the contribution of immunosenescence to age-related increases in disease susceptibility and mortality
History of clinical transplantation
How transplantation came to be a clinical discipline can be pieced together by perusing two volumes of reminiscences collected by Paul I. Terasaki in 1991-1992 from many of the persons who were directly involved. One volume was devoted to the discovery of the major histocompatibility complex (MHC), with particular reference to the human leukocyte antigens (HLAs) that are widely used today for tissue matching.1 The other focused on milestones in the development of clinical transplantation.2 All the contributions described in both volumes can be traced back in one way or other to the demonstration in the mid-1940s by Peter Brian Medawar that the rejection of allografts is an immunological phenomenon.3,4 © 2008 Springer New York
- …